Nonfasting Plasma Total Homocysteine Level and Mortality

  1. Jeremy D. Kark, MD, PhD;
  2. Joseph H. Abramson, MB, BCh; and
  3. Irwin H. Rosenberg, MD
  1. Hadassah Medical Organization and Hebrew University; Ein Kerem, Jerusalem 91120 (Kark) Hadassah Medical Organization and Hebrew University; Ein Kerem, Jerusalem 91120 (Abramson) Tufts University; Boston, MA 02111 (Rosenberg)

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    IN RESPONSE: …

    « Previous | Next Article »Table of Contents